Published in Stroke on October 01, 2000
uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPK. Brain Res (2008) 1.09
Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia/ischemia through inhibition of ERK MAPK activation. J Cereb Blood Flow Metab (2009) 1.02
Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders. J Neurochem (2010) 0.98
Mechanisms of perinatal arterial ischemic stroke. J Cereb Blood Flow Metab (2014) 0.93
Therapeutic approaches and advances in pediatric stroke. NeuroRx (2006) 0.92
Stem cells for brain repair in neonatal hypoxia-ischemia. Childs Nerv Syst (2013) 0.87
Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers. Indian J Hum Genet (2012) 0.87
PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia. Am J Physiol Heart Circ Physiol (2010) 0.84
Association between hypoxia and perinatal arterial ischemic stroke: a meta-analysis. PLoS One (2014) 0.84
The black box of perinatal ischemic stroke pathogenesis. J Child Neurol (2011) 0.82
Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia. Am J Physiol Heart Circ Physiol (2009) 0.82
tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK. Brain Res (2010) 0.82
Inherited prothrombotic risk factors in children with first ischemic stroke. Biochem Med (Zagreb) (2012) 0.81
Perinatal stroke: a case-based review. Eur J Pediatr (2011) 0.81
Modeling Ischemia in the Immature Brain: How Translational Are Animal Models? Stroke (2015) 0.79
MRI for the management of neonatal cerebral infarctions: importance of timing. Childs Nerv Syst (2004) 0.77
Perinatal Arterial Ischemic Stroke Is Associated to Materno-Fetal Immune Activation and Intracranial Arteritis. Int J Mol Sci (2016) 0.75
Intrauterine upper limb ischemia: an unusual presentation of fetal thrombophilia-a case report and review of the literature. Case Rep Pediatr (2013) 0.75
RBC-coupled tPA Prevents Whereas tPA Aggravates JNK MAPK-Mediated Impairment of ATP- and Ca-Sensitive K Channel-Mediated Cerebrovasodilation After Cerebral Photothrombosis. Transl Stroke Res (2012) 0.75
PAI-1-derived peptide EEIIMD prevents hypoxia/ischemia-induced aggravation of endothelin- and thromboxane-induced cerebrovasoconstriction. Neurocrit Care (2014) 0.75
Evaluation of hypercoagulability state in perinatal arterial ischemic stroke with rotation thromboelastometry. Childs Nerv Syst (2016) 0.75
DNA: an extensible molecule. Science (1996) 8.19
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood (2001) 1.75
Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke (2001) 1.71
C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J (2000) 1.63
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost (2010) 1.62
Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke (2003) 1.58
Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost (2002) 1.56
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J (1999) 1.48
Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J (2002) 1.47
Cerebral venous thrombosis in children: a multifactorial origin. Circulation (2003) 1.46
Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost (1998) 1.43
Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem (2001) 1.43
Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol (2001) 1.41
Foetal growth restriction in children with prothrombotic risk factors. Thromb Haemost (2001) 1.39
Measurement of prostate-specific antigen: no advantage to ultrasensitive assays? J Natl Cancer Inst (1996) 1.39
ELECTRON MAGNETIC RESONANCE OF CH(COOH)(2). Proc Natl Acad Sci U S A (1959) 1.38
Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res (1996) 1.37
Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. Eur J Cancer (1996) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol (1999) 1.34
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32
Minor head injury as cause and co-factor in the aetiology of stroke in childhood: a report of eight cases. J Neurol Neurosurg Psychiatry (2002) 1.31
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. FASEB J (1999) 1.27
Repression of gene expression by cdll products in Paramecium. Genetics (1967) 1.26
Segregation in DNA solutions induced by electric fields. Science (1995) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr (2000) 1.15
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood (2000) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia. Br J Haematol (1997) 1.13
Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res (2001) 1.10
Individualized developmental care for very-low-birth-weight premature infants. Clin Pediatr (Phila) (1995) 1.09
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. Br J Haematol (2000) 1.09
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
[Sequencing of DNA by mechanical opening of the double helix: a theoretical evaluation]. C R Acad Sci III (1994) 1.06
Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost (2002) 1.05
Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation (1999) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols. Br J Haematol (1999) 1.01
Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. Acta Paediatr (2002) 1.01
Clonal variation in paramecium. Heterogeneity within clones of identical serotypes. Genetics (1972) 1.01
High prevalence of the I278T mutation of the human cystathionine beta-synthase detected by a novel screening application. Thromb Haemost (2001) 1.00
Role of non-surface antigens in controlling Paramecium surface antigen synthesis. J Protozool (1969) 1.00
Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. J Thromb Haemost (2011) 1.00
Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr (1999) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia. Eur J Pediatr (1998) 0.97
Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin Genet (2010) 0.97
Role of genetic prothrombotic risk factors in childhood caval vein thrombosis. Eur J Pediatr (1999) 0.95
Corrosion and biocompatibility of orthodontic wires. J Mater Sci Mater Med (1999) 0.94
DNA sequencing with direct blotting electrophoresis and colorimetric detection. Biotechniques (1989) 0.94
Prevalence of factor V Leiden in children with thrombo-embolism. Eur J Pediatr (1996) 0.94
Thrombolysis in newborns and infants. Thromb Haemost (1999) 0.93
Clonal variation in paramecium. II. A comparison of stable and unstable clones of the same serotype. Genetics (1972) 0.92
Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T. Eur J Pediatr (2000) 0.92
Clonal variation in paramecium. I. Persistent unstable clones. Genetics (1972) 0.92
The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate. Acta Derm Venereol (1992) 0.92
High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost (2001) 0.91
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN). Haemophilia (2012) 0.91
Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss. Hear Res (2004) 0.90
Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke (1998) 0.90
High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesth Analg (1999) 0.89
Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis. Haemophilia (2011) 0.89
An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men. Int J Epidemiol (1999) 0.89
Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis (1996) 0.89
Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost (2001) 0.88
The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) (2001) 0.88
Identification and characterization of P(1), P(7)-Di(adenosine-5')-heptaphosphate from human platelets. J Biol Chem (1999) 0.88
Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. J Neurol (1998) 0.88
Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies. Eur J Pediatr (2012) 0.88
Isolated thrombosis due to the cystathionine beta-synthase mutation c.833T>C (1278T). J Inherit Metab Dis (2003) 0.87
Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol (1999) 0.87
Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (1999) 0.87
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas. Br J Cancer (2006) 0.87